David Gilligan
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: August 11, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.
Journal: NPJ precision oncology
Published: July 30, 2024
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 15, 2024
Making an accurate diagnosis of anterior mediastinal lesions: a proposal for a new diagnostic algorithm from the BTOG Thymic Malignancies Special Interest Group.
Journal: Clinical radiology
Published: January 04, 2024
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.
Journal: Journal for immunotherapy of cancer
Published: September 03, 2023
Thymic epithelial tumour radiotherapy in the UK: A survey of current clinical practice.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 05, 2023
A case of malignant mesothelioma in a young patient with childhood leukaemia who had received total body irradiation.
Journal: Oxford medical case reports
Published: September 12, 2022
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 14, 2022
Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.
Journal: JCO precision oncology
Published: January 07, 2022
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 12, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 10, 2021
Last Updated: 09/26/2026